Higher Cell-Mediated Immune Responses in Patients With Inflammatory Bowel Disease on Anti-TNF Therapy After COVID-19 Vaccination.

Freddy CalderaFrancis A FarrayeBrian M NecelaDavitte CogenSumona SahaArnold WaldNader D DaoudKelly ChunIan GrimesMegan LutzSean R Van HeldenMelanie D SwiftAbinash VirkAdil E BharuchaTushar C PatelGregory J GoresSaranya ChumsriMary S HayneyKeith L Knutson

Published in: Inflammatory bowel diseases (2022)

Most patients with IBD achieved CMIR to a COVID-19 vaccine. Future studies are needed evaluating sustained CMIR and clinical outcomes.

Keyphrases

coronavirus disease
patients with inflammatory bowel disease
sars cov
immune response
cell therapy
rheumatoid arthritis
respiratory syndrome coronavirus
current status
stem cells
mesenchymal stem cells
bone marrow
replacement therapy